Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell Lymphoma

Phase 2 Unknown 30 enrolled Fudan University

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy and tolerability of radiotherapy followed by adjuvant chemotherapy in stage I/II NK/T-cell lymphoma.

Timeline

Start: 2012-06
Primary completion: 2013-12
Completion: 2016-12

Publications

Liu Y, Xue K, Xia Z, Jin J, Wang J, Sun H, Lv F, Liu X, Cao J, Hong X, Guo Y, Ma X, Zhang Q. Radiotherapy followed by DICEP regimen in treatment of newly diagnosed, stage IE/IIE, extranodal NK/T-cell lymphoma patients. Cancer Med. 2020 Aug;9(15):5400-5405. doi: 10.1002/cam4.3207. Epub 2020 Jun 9.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cisplatin	Other / unclassified	20 mg/m2	—
Subject	Dexamethasone	Small molecule	40 mg	—
Subject	Etoposide	Small molecule	60 mg/m2	—
Subject	Ifosfamide	Small molecule	1200 mg/m2	—
Subject	Pegaspargase	Protein / enzyme biologic	2000 iu	—

Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell Lymphoma

Summary

Timeline

Publications

Drugs

Indications